+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cryptococcosis Treatment Market by Drug Class (Azoles, Flucytosine, Polyenes), End User (Clinics, Home Care, Hospitals), Administration Route, Distribution Channel, Patient Type - Global Forecast 2025-2030- Product Image
Cryptococcosis Treatment Market by Drug Class (Azoles, Flucytosine, Polyenes), End User (Clinics, Home Care, Hospitals), Administration Route, Distribution Channel, Patient Type - Global Forecast 2025-2030- Product Image
Sale

Cryptococcosis Treatment Market by Drug Class (Azoles, Flucytosine, Polyenes), End User (Clinics, Home Care, Hospitals), Administration Route, Distribution Channel, Patient Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5012985
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cryptococcosis treatment market is undergoing significant transformation as advanced therapies, digital innovations, and evolving care protocols reshape how healthcare organizations and pharmaceutical stakeholders manage this dangerous fungal infection. Understanding the changing dynamics and precise market segmentation can help decision-makers align strategies for clinical effectiveness and commercial growth.

Market Snapshot: Growth and Opportunity in Cryptococcosis Treatment

The Cryptococcosis Treatment Market grew from USD 7.77 billion in 2024 to USD 8.24 billion in 2025. It is expected to continue growing at a CAGR of 5.96%, reaching USD 11.00 billion by 2030. The sector is shaped by increasing demand for advanced antifungal formulations, digital health integration, and targeted care pathways across diverse patient populations. Pharmaceutical procurement executives, clinical leadership, and health system strategists must consider evolving pricing structures and real-world care challenges as they navigate regional and global market complexities.

Scope & Segmentation: Defining the Cryptococcosis Treatment Market

This report dissects the key dimensions and segments that drive innovation in cryptococcosis treatment:

  • Drug Classes: Azoles (including fluconazole, posaconazole, voriconazole), Flucytosine, and Polyenes (amphotericin B deoxycholate, liposomal amphotericin B)
  • End Users: Clinics, outpatient clinics, specialist clinics, home care providers, and hospitals
  • Administration Routes: Intravenous methods (central line, peripheral) and oral formulations (suspensions, tablets)
  • Distribution Channels: Offline wholesalers and online platforms
  • Patient Types: HIV-infected populations, immunocompetent individuals, and transplant recipients
  • Geographical Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), EMEA (key markets including UK, Germany, France, Saudi Arabia, South Africa, and others), Asia-Pacific (notably China, India, Japan, Australia, and Southeast Asia)
  • Key Companies: Pfizer Inc., Gilead Sciences, Bausch Health Companies, Teva Pharmaceuticals, Viatris, Astellas Pharma, Cipla, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, Lupin Limited

Key Takeaways for Decision-Makers

  • Therapeutic approaches rely increasingly on next-generation azoles, innovative polyene formulations, and co-formulated regimens to address both efficacy and safety concerns.
  • Molecular diagnostics and point-of-care technologies are accelerating the speed and accuracy of early cryptococcosis detection, supporting better clinical outcomes.
  • Digital health platforms and telemedicine are being deployed to enhance patient adherence, support long-term suppressive therapy, and enable remote monitoring, particularly where healthcare access is constrained.
  • Segmented treatment strategies are required to meet the specific needs of HIV-infected individuals, immunocompetent patients, and post-transplant populations, each with unique risk profiles and duration requirements.
  • Partnerships between global innovators and regional manufacturers have become critical to accelerating production and improving affordability, especially where generic options and rapid supply are essential.

Tariff Impact: Navigating US Tariff Adjustments

The 2025 adjustment of United States tariffs on pharmaceutical imports has triggered considerable shifts in pricing and supply chain strategies across antifungal therapies. Stakeholders are diversifying manufacturing bases and seeking regional production to offset shipping and customs fluctuations. These moves have impacted both procurement models and reimbursement plans, as market participants aim to balance cost efficiency with uninterrupted access to lifesaving treatments. Ongoing policy dialogue and international trade alignment remain central to safeguarding patient access within this context.

Methodology & Data Sources

This research derives insights from primary interviews with infectious disease experts, pharmacists, payers, and procurement leaders, combined with secondary source review of peer-reviewed journals, regulatory filings, and public health databases. Cross-validation included data triangulation, collaboration with local subject matter specialists, and critical review of trade and customs data to ensure integrity and transparency of findings.

Why This Report Matters

  • Delivers actionable segmentation and technology insights to optimize R&D, procurement, and policy strategies in antifungal therapeutics.
  • Equips senior leaders with a granular understanding of regulatory, supply, and patient access factors critical to competitive positioning and sustained market growth.

Conclusion

The cryptococcosis treatment market stands at a strategic point, driven by diagnostic, therapeutic, and policy innovation. Informed, collaborative approaches and an evidence-based view will help decision-makers shape more resilient, patient-centered treatment landscapes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in liposomal amphotericin B formulations to improve central nervous system penetration
5.2. Clinical trials evaluating the efficacy of novel triazole derivatives against resistant Cryptococcus strains
5.3. Integration of rapid molecular diagnostic assays for early detection of cryptococcal antigen in resource limited settings
5.4. Emerging combination therapies leveraging immunomodulators to enhance host response in cryptococcosis patients
5.5. Adoption of long acting injectable antifungal agents to improve adherence in HIV associated cryptococcal meningitis
5.6. Increasing focus on decentralized point of care testing for cryptococcal antigen to enable community based screening
5.7. Development of nanoparticle based drug delivery systems to target Cryptococcus neoformans in the brain
5.8. Regulatory strategies accelerating orphan drug designation for innovative cryptococcosis therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cryptococcosis Treatment Market, by Drug Class
8.1. Introduction
8.2. Azoles
8.2.1. Fluconazole
8.2.2. Posaconazole
8.2.3. Voriconazole
8.3. Flucytosine
8.4. Polyenes
8.4.1. Amphotericin B Deoxycholate
8.4.2. Liposomal Amphotericin B
9. Cryptococcosis Treatment Market, by End User
9.1. Introduction
9.2. Clinics
9.2.1. Outpatient Clinics
9.2.2. Specialist Clinics
9.3. Home Care
9.4. Hospitals
10. Cryptococcosis Treatment Market, by Administration Route
10.1. Introduction
10.2. Intravenous
10.2.1. Central Line
10.2.2. Peripheral
10.3. Oral
10.3.1. Suspension
10.3.2. Tablet
11. Cryptococcosis Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Cryptococcosis Treatment Market, by Patient Type
12.1. Introduction
12.2. HIV Infected
12.3. Non-HIV Infected
12.3.1. Immunocompetent
12.3.2. Transplant Patients
13. Americas Cryptococcosis Treatment Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cryptococcosis Treatment Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cryptococcosis Treatment Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Gilead Sciences, Inc.
16.3.3. Bausch Health Companies Inc.
16.3.4. Teva Pharmaceutical Industries Ltd.
16.3.5. Viatris Inc.
16.3.6. Astellas Pharma Inc.
16.3.7. Cipla Limited
16.3.8. Dr. Reddy's Laboratories Ltd.
16.3.9. Sun Pharmaceutical Industries Limited
16.3.10. Lupin Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CRYPTOCOCCOSIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CRYPTOCOCCOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CRYPTOCOCCOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CRYPTOCOCCOSIS TREATMENT MARKET: RESEARCHAI
FIGURE 26. CRYPTOCOCCOSIS TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 27. CRYPTOCOCCOSIS TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 28. CRYPTOCOCCOSIS TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CRYPTOCOCCOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY FLUCONAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY FLUCONAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POSACONAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POSACONAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY VORICONAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY VORICONAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY FLUCYTOSINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY FLUCYTOSINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AMPHOTERICIN B DEOXYCHOLATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AMPHOTERICIN B DEOXYCHOLATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY LIPOSOMAL AMPHOTERICIN B, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY LIPOSOMAL AMPHOTERICIN B, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY SPECIALIST CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY SPECIALIST CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CENTRAL LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CENTRAL LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HIV INFECTED, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HIV INFECTED, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY IMMUNOCOMPETENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY IMMUNOCOMPETENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY TRANSPLANT PATIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY TRANSPLANT PATIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 129. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 130. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 131. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 132. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 133. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2024 (USD MILLION)
TABLE 134. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2025-2030 (USD MILLION)
TABLE 135. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 138. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 139. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 140. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 141. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 142. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 143. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 144. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 145. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 148. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 149. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2024 (USD MILLION)
TABLE 150. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2025-2030 (USD MILLION)
TABLE 151. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 154. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 155. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2024 (USD MILLION)
TABLE 156. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2025-2030 (USD MILLION)
TABLE 157. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 166. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 167. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 170. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2024 (USD MILLION)
TABLE 172. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2025-2030 (USD MILLION)
TABLE 263. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 264. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 265. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 266. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 267. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2024 (USD MILLION)
TABLE 268. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2025-2030 (USD MILLION)
TABLE 269. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 272. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 274. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 275. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 276. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 277. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 278. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 279. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 282. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 283. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2024 (USD MILLION)
TABLE 284. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2025-2030 (USD MILLION)
TABLE 285. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 286. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 287. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 288. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 289. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2024 (USD MILLION)
TABLE 290. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2025-2030 (USD MILLION)
TABLE 291. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 294. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 295. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 296. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 297. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 298. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 299. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 300. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 301. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 304. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 305. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2024 (USD MILLION)
TABLE 306. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 327. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2024 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

  • Pfizer Inc.
  • Gilead Sciences, Inc.
  • Bausch Health Companies Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Astellas Pharma Inc.
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Sun Pharmaceutical Industries Limited
  • Lupin Limited

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.24 Billion
Forecasted Market Value ( USD ) by 2030 $ 11 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Cryptococcosis Market by Drug Class (Azoles, Echinocandins, Polyenes), Indication (Cryptococcal Meningitis, Disseminated Cryptococcosis, Pulmonary Cryptococcosis), Route Of Administration, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Cryptococcosis Market by Drug Class (Azoles, Echinocandins, Polyenes), Indication (Cryptococcal Meningitis, Disseminated Cryptococcosis, Pulmonary Cryptococcosis), Route Of Administration, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Cryptococcosis Therapeutics - Global Strategic Business Report - Product Image

Cryptococcosis Therapeutics - Global Strategic Business Report

  • Report
  • 473 Pages
  • Global
From
Cryptococcosis Treatment - Global Strategic Business Report - Product Image

Cryptococcosis Treatment - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Cryptococcosis Market Report 2025 - Product Image

Cryptococcosis Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.